Read More 1 minute read Analyst Ratings News Price Target Upgrades Gordon Haskett Upgrades TJX Companies to Buy, Announces $80 Price Target By Benzinga Newsdesk November 10, 8:45 AM Gordon Haskett analyst Chuck Grom upgrades TJX Companies (NYSE:TJX) from Hold to Buy and announces $80 price target. TJX
Read More 1 minute read Analyst Ratings News Price Target Upgrades Raymond James Upgrades AeroVironment to Outperform, Announces $100 Price Target By Benzinga Newsdesk November 10, 7:14 AM Raymond James analyst Brian Gesuale upgrades AeroVironment (NASDAQ:AVAV) from Market Perform to Outperform and announces $100 price target. AVAV
Read More 1 minute read Analyst Ratings News Price Target Upgrades UBS Upgrades Viatris to Neutral, Raises Price Target to $12 By Benzinga Newsdesk November 10, 5:54 AM UBS analyst Ashwani Verma upgrades Viatris (NASDAQ:VTRS) from Sell to Neutral and raises the price target from $9 to $12. VTRS
Read More 2 minute read Analyst Color Analyst Ratings Downgrades News Penny Stocks Price Target Reiteration Upgrades Velodyne Lidar Analysts Expect Cost Cut Measures To Drive Bottom Line; Bet Big On Ouster Acquisition By Anusuya Lahiri November 9, 2:42 PM Needham analyst Rajvindra Gill reiterated Buy on Velodyne Lidar, Inc (NASDAQ:VLDR) with a $3 price target. Velodyne announced additional cost-cutting measures, which… OUST
Read More 1 minute read Analyst Ratings News Upgrades OTR Global Upgrades Macy’s to Positive By Benzinga Newsdesk November 9, 10:26 AM OTR Global upgrades Macy's (NYSE:M) from Mixed to Positive. M
Read More 1 minute read Analyst Ratings News Price Target Upgrades Compass Point Upgrades SLR Investment to Buy, Announces $15.75 Price Target By Benzinga Newsdesk November 9, 10:18 AM Compass Point analyst Casey Alexander upgrades SLR Investment (NASDAQ:SLRC) from Neutral to Buy and announces $15.75 price target. SLRC
Read More 1 minute read Analyst Ratings News Price Target Upgrades Goldman Sachs Upgrades Allscripts Healthcare to Buy, Raises Price Target to $23 By Benzinga Newsdesk November 9, 8:50 AM Goldman Sachs analyst Cindy Motz upgrades Allscripts Healthcare (NASDAQ:MDRX) from Neutral to Buy and raises the price target from $22 to $23. MDRX
Read More 1 minute read Analyst Ratings News Price Target Upgrades Credit Suisse Upgrades NiSource to Outperform, Announces $27 Price Target By Benzinga Newsdesk November 9, 8:22 AM Credit Suisse analyst Nicholas Campanella upgrades NiSource (NYSE:NI) from Neutral to Outperform and announces $27 price target. NI
Read More 1 minute read Analyst Ratings News Price Target Upgrades B of A Securities Upgrades Kite Realty Gr Trust to Buy, Raises Price Target to $25 By Benzinga Newsdesk November 9, 7:27 AM B of A Securities analyst Craig Schmidt upgrades Kite Realty Gr Trust (NYSE:KRG) from Neutral to Buy and raises the price target from $22 to $25. KRG
Read More 1 minute read Analyst Ratings News Price Target Upgrades Rosenblatt Upgrades Quotient Technology to Buy, Announces $3.5 Price Target By Benzinga Newsdesk November 9, 7:20 AM Rosenblatt analyst Steve Frankel upgrades Quotient Technology (NYSE:QUOT) from Neutral to Buy and announces $3.5 price target. QUOT